Products & Services  | Science | About LifeSpan | Drug TargetTM  | Register 
Quick Search: 
 Antibody Search
 
 Conferences  |  Articles & Press Releases  |  Careers  |  Contact Us  |  Distributors


Robert LoBosco

LIFESPAN BIOSCIENCES NAMES ROBERT LOBOSCO, FORMER LEADER IN MERCK'S GLOBAL IT ORGANIZATION, AS CHIEF INFORMATION OFFICER

SEATTLE, WA (April 17, 2002) — LifeSpan Biosciences, Inc., a world leader in the emerging fields of molecular pathology and tissue proteomics, today announced the appointment of Robert A. LoBosco as Vice President and Chief Information Officer. Mr. LoBosco, most recently the Vice President of Software Engineering at Hotjobs.com, worked from 1997 to 1999 as a senior leader in information technology at Merck & Co., Inc., where he led global initiatives to streamline that company’s business-critical IT infrastructure.

“We are delighted to gain an IT executive with the substantial pharmaceutical and scientific computing background of Robert LoBosco,” said Joseph Brown, Ph.D., LifeSpan President and Chief Executive Officer. “His first-hand understanding of the IT needs of major pharmaceutical research firms will help us continue to augment the value of our offerings. We are very pleased to welcome Robert to the LifeSpan management team.”

Prior to joining Merck, Mr. LoBosco ran a software consulting company that developed Satellite software systems for NASA and the Department of Defense, including work on a Mars orbiter, from 1990 to 1997. His career in software engineering started at Sikorsky Aircraft where, from 1986 to 1990, he developed battleground simulation software for U.S. ARMY attack helicopters. Mr. LoBosco received a B.S. degree in computer engineering from the University of Bridgeport, Connecticut.

About LifeSpan Biosciences, Inc.

LifeSpan Biosciences, headquartered in Seattle, Washington, is a privately held genomics company founded in 1995 that utilizes proprietary molecular pathology and bioinformatics technology to profile and localize gene expression in normal and diseased human tissues for its more than 50 pharmaceutical company customers in Europe, Asia and North America. LifeSpan is currently applying its technology and expertise to the production of a comprehensive atlas on the expression of each of the 30,000 human genes in both normal and diseased tissues. For more information on LifeSpan Biosciences, contact Joseph P. Brown, Ph.D., CEO at 206/ 464-1554 or joe@lsbio.com, or visit the company’s website at www.lsbio.com.


Copyright © 2005 LifeSpan, Inc. All Rights Reserved